News Roundup: October 31 to November 4
Your weekly roundup of the latest news from Drug Topics®.
Pharmacy Finance Pitfalls to Avoid
Pharmacy finances can suffer if owners are tripped up by these common pitfalls.
What Do the Midterms Mean for Pharmacy?
Independent pharmacists stand to gain—or lose—depending on what happens at the polls in November 2022.
Crisis (Not) Averted
It’s too late for retail chain pharmacies to engage in the preventive maintenance that would have spared them the worst of the Great Resignation.
FDA Approves Olipudase Alfa-rpcp for Acid Sphingomyelinase Deficiency
Acid sphingomyelinase deficiency is a rare, progressive genetic disease associated with significant morbidity and mortality.
Flu Shots and Ischemic Stroke Risk in Older Adults
Recently published research reveals an important benefit for middle-aged and older adults: a reduction in ischemic stroke risk.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
